ARTICLE | Company News
Advanced Life submits NDA, partners with Wyeth
October 2, 2008 1:17 AM UTC
Advanced Life Sciences (NASDAQ:ADLS) submitted an NDA to FDA for cethromycin to treat mild to moderate community-acquired pneumonia (CAP). The company also granted Wyeth (NYSE:WYE) exclusive rights to...